In a regulatory 13D/A filing, RA Capital disclosed that it has increased its stake in Tyra Biosciences (TYRA) to 22.4% from 20.1% reported in March. Shares were up 3% at $10.50 at the conclusion of the afterhours session.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TYRA:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue